2017
Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference
Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. American Journal Of Transplantation 2017, 17: 901-911. PMID: 27997071, DOI: 10.1111/ajt.14173.Peer-Reviewed Original ResearchConceptsEnd-stage renal diseaseAPOL1 risk allelesApolipoprotein 1Risk allelesKidney donationEvidence-based guidelinesClinical decision-making processAmerican SocietyAPOL1 gene variantsPercent of individualsKidney transplantationRenal transplantationRenal diseaseCase reportGeneral populationClinical practiceTransplantationAPOL1 variantsGene variantsKidneyAfrican ancestryCurrent dataExpert conferenceLimited studiesReport
2016
Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation
Azar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. International Journal Of STD & AIDS 2016, 28: 447-458. PMID: 27193421, DOI: 10.1177/0956462416651528.Peer-Reviewed Original ResearchConceptsInhibitor-based regimensRenal transplantationHIV/AIDSAntiretroviral regimenAntiretroviral therapyGraft survivalHIV-positive renal transplant recipientsEnd-stage renal diseaseHIV-positive patientsRenal transplant recipientsChronic kidney diseaseThree-year survivalInhibitor-based therapyNon-nucleoside reverseDrug-drug interactionsTransferase inhibitorsImmunosuppressive medicationsKidney transplantationTransplant recipientsAllograft rejectionGraft failureRenal diseaseCalcineurin inhibitorsClinical outcomesImmunosuppressive drugs
2011
Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy
Kulkarni S, Emre S, Arvelakis A, Asch W, Bia M, Formica R, Israel G. Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy. Clinical Transplantation 2011, 25: 77-82. PMID: 20070320, DOI: 10.1111/j.1399-0012.2009.01193.x.Peer-Reviewed Original ResearchConceptsVenous anatomyVenous phaseMDCT angiographyRenal anatomyCircumaortic renal veinDonor renal transplantationEarly arterial bifurcationLate venous confluenceMultiple arterial anomaliesRight donor nephrectomyIntra-operative findingsMultiple venous anomaliesContrast-enhanced phasesArterial anomaliesRetroaortic veinRenal transplantationDonor nephrectomyMultiple arteriesVenous anomaliesRenal veinVenous confluenceKidney donorsTomography angiographyAnatomical variantsDonor anatomy
2010
Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature
Cuffy MC, Singh M, Formica R, Simmons E, Abu Alfa AK, Carlson K, Girardi M, Cowper SE, Kulkarni S. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrology Dialysis Transplantation 2010, 26: 1099-1101. PMID: 21079195, DOI: 10.1093/ndt/gfq693.Peer-Reviewed Case Reports and Technical NotesConceptsNephrogenic systemic fibrosisRenal transplantationSystemic fibrosisSymptoms of NSFEarly renal transplantationUnderwent renal transplantationRare fibrosing disorderStandard therapy existsRenal functionFibrosing disorderRenal diseaseCase reportTherapy existsPatient's lesionTherapeutic modalitiesTransplantationPatientsLesionsFibrosisPhotopheresisPlasmapheresisImatinibSymptomsCareful considerationDisease
2008
Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis
Yarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2008, 24: 1039-1047. PMID: 19103734, DOI: 10.1093/ndt/gfn667.Peer-Reviewed Original ResearchConceptsGraft survivalAcute rejectionPatient survivalGraft functionSystematic reviewHigher mean serum creatinineDelayed graft functionMean serum creatinineLong-term outcomesDGF groupGraft lossGraft outcomeRenal transplantationCommon complicationRenal functionSecondary outcomesSerum creatininePrimary outcomeKidney functionMean creatinineKidney donorsPatientsDetrimental associationDGFLiterature search
2006
A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period
Formica RN, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrology Dialysis Transplantation 2006, 21: 1389-1394. PMID: 16431893, DOI: 10.1093/ndt/gfk058.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAmlodipineBlood Pressure DeterminationChi-Square DistributionDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHumansHypertensionKidney Failure, ChronicKidney TransplantationLosartanMaleMiddle AgedProbabilityRisk AssessmentSeverity of Illness IndexTreatment OutcomeConceptsRenal transplant recipientsPost-transplant periodEarly post-transplant periodARB useUse of ARBInitial therapyCCB groupImmediate post-transplant periodPost-transplant erythrocytosisPost-transplant hypertensionRisk of hyperkalaemiaPost-transplant managementSerum creatinine levelsChronic kidney diseaseII receptor blockersCalcium channel blockersNumber of patientsAldosterone systemARB groupKidney transplantationRenal transplantationTransplant recipientsCreatinine levelsRenal functionBlood pressure